Rectify Pharmaceuticals

United States
Primghar, Iowa, United States, 02139

Company profile

Rectify Pharmaceuticals company profile

Rectify is developing disease-modifying precision therapies that restore ABC transporter function to address the underlying cause of serious genetic diseases. The company’s pipeline spans multiple therapeutic areas.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$1M-$10M
Founded
2020-01-01, Year

Headquarters

Postal code
02139
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$100M
Last funding
Series A / $100M / 2021-10-14
Last equity funding
Series A / $100M
Investors
4
Lead investors
4
Founders
1
Articles
22

Founders and investors

Founders

Jonathan Moore

Lead investors

Atlas VentureForbion Capital PartnersLongwood FundOmega Funds

Investors

Atlas VentureForbion Capital PartnersLongwood FundOmega Funds